🇺🇸 Levonorgestrel IUS in United States
125 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 125
Most-reported reactions
- Drug Ineffective — 25 reports (20%)
- Pregnancy With Contraceptive Device — 20 reports (16%)
- Device Dislocation — 12 reports (9.6%)
- Device Expulsion — 12 reports (9.6%)
- Embedded Device — 12 reports (9.6%)
- Genital Haemorrhage — 10 reports (8%)
- Device Use Issue — 9 reports (7.2%)
- Procedural Pain — 9 reports (7.2%)
- Abdominal Pain — 8 reports (6.4%)
- Medical Device Pain — 8 reports (6.4%)
Other Contraception / Gynecology approved in United States
Frequently asked questions
Is Levonorgestrel IUS approved in United States?
Levonorgestrel IUS does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Levonorgestrel IUS in United States?
Oregon Health and Science University is the originator. The local marketing authorisation holder may differ — check the official source linked above.